Was Ondine Biomedical hit by ransomware?

Ondine Biomedical was listed by the Incransom ransomware operation (Canada), and stolen data was published on the group's leak site. Darkfield tracks this disclosure with the original leak post, screenshot and group context.

Who is the Incransom ransomware group?

Incransom is a ransomware operator tracked by Darkfield. See the full operator dossier for its known victims, sectors targeted, IOCs and leak-site infrastructure.

What data was leaked in the Ondine Biomedical breach?

Incransom published data attributed to Ondine Biomedical. Darkfield captured the leak post and a screenshot of the listing.

Ransomware victim disclosure

← All victims

Ondine Biomedical

Claimed by Incransom · listed 4 months ago

Age

since listed · data leaked

Status timeline

ListedFeb 16, 2026
Data leakeddate unknown

At a glance

Group: Incransom
Status: Data leaked
Country: Canada
Sector: Healthcare
Listed on leak site: Feb 16, 2026

About the victim

AI dossier — public-source company profile

Ondine Biomedical Inc. is a Canadian biomedical company founded and led by CEO Carolyn Cross. The company has developed a patented photodisinfection technology platform used in treatment and prevention therapies targeting a broad spectrum of pathogens, including multidrug-resistant strains. The technology is not currently approved in the United States, indicating the company operates primarily in non-US markets.

Industry: Biomedical Technology & Photodisinfection Therapeutics

Attack summary

Severity: high — The victim operates in the healthcare/biomedical sector, and the group claims imminent full data publication, indicating exfiltration of potentially sensitive business, clinical, or proprietary R&D data. Healthcare sector breaches with confirmed exfiltration and threatened publication warrant high severity, though the absence of confirmed PII at scale or specific data inventory prevents a critical rating.

Incransom claims to have obtained data from Ondine Biomedical Inc. and states it will publish all information the following week, suggesting exfiltration of company data with a threatened full public disclosure.

high

Data the group says was taken

AI dossier — extracted from the leak post

Undisclosed company data (pending publication)

What the group claims

Ondine Biomedical Inc. is a Canadian headquartered company led by founder and CEO, Carolyn Cross. Ondine has developed a patented, photodisinfection technology platform used in treatment and prevention therapies for a broad-spectrum of pathogens - including multidrug-resistant strains. Photodisinfection, which is not currently approved in the United States We will publish all the information next week.

Sources

Leak posthttp://incblog6qu4y4mm4zvw5nrmue6qbwtgjsxpw6b7ixzssu36tsajldoad.onion/blog/disclosures/6991a8838f1d14b743c5c963

Source

Indexed 4 months ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Incransom

Incransom is a ransomware group that emerged in August 2023, operating with primarily financial motivations as evidenced by their targeting of high-value sectors across multiple developed nations. The group's origin and specific affiliations remain undocumented by major threat intelligence organizations, though their operational patterns suggest they likely operate independently rather than as a ransomware-as-a-service model. With 734 documented victims, Incransom has demonstrated a preference for targeting organizations in the United States, Canada, United Kingdom, Germany, and Australia, with particular focus on healthcare, technology, business services, and manufacturing sectors, though their attack methodology and specific technical capabilities have not been extensively documented by established security researchers or government agencies. The group's notable campaigns and specific high-profile victims have not been publicly detailed by CISA, FBI, Mandiant, or other reputable threat intelligence sources, suggesting either operational security effectiveness or limited visibility into their most significant operations. Based on available intelligence, Incransom appears to remain active as of recent reporting periods, though comprehensive analysis of their current operational status requires additional documentation from established threat intelligence sources. The group has been linked to 829 public disclosures across our corpus. First observed on a leak site on August 9, 2023; most recent post June 11, 2026. The operation is currently active.

Also tracked as: inc ransom.

Timeline of this disclosure

February 16, 2026Ondine Biomedical listed by Incransomon the group's public leak site

Other recent disclosures by Incransom

Incransom has been linked to 829 public victims on Darkfield. A sample of the most recent:

See the full Incransom dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 1,780 disclosures indexed across all operators we track. Geographically, Ondine Biomedical is reported in Canada, a country with 810 ransomware disclosures in our corpus.

If your organisation is affected

A listing by Incransom means Ondine Biomedical appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
Monitor for the data appearing on Incransom's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.